Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Paramita Bangun Sarana Tbk. (PBSA)

UBC Medical Indonesia Tbk.Trading
Paramita Bangun Sarana Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Paramita Bangun Sarana Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp162 (kapitalisasi pasar 635,95 M, volume 24 jam 218,3 rb), sedangkan Paramita Bangun Sarana Tbk. diperdagangkan di Rp885 (kapitalisasi pasar 2,22 T, volume 24 jam 5,86 jt). Perbedaan utamanya: Paramita Bangun Sarana Tbk. jauh lebih besar — sekitar 3,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Paramita Bangun Sarana Tbk. lebih aktif diperdagangkan (5,86 jt vs 218,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSPBSA
Kapitalisasi Pasar
635,95 M2,22 T
Volume
218,3 rb5,86 jt
Lot
2,18 rb58,58 rb
Perputaran
35,51 jt4,89 M
Harga Rata-rata
162,69835,05
Nilai Transaksi
35,51 jt4,89 M
Harga Ekuilibrium Indikatif
163760
Volume Ekuilibrium Indikatif
16675

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
PBSA
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Paramita Bangun Sarana Tbk.

PT. Paramita Bangun Sarana Tbk (the Company) was established based on the Notarial Deed No. 33 of Lenny Janis Ishak, S.H., dated November 27, 2002.

Selengkapnya di halaman PBSA